Intelligent Pharmacy

KeAi Communications Co., Ltd.

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Intelligent Pharmacy is an open-access journal published by KeAi Communications Co., Ltd. in China, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,200 USD. Declared review time at DOAJ: 20 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
KeAi Communications Co., Ltd.
ISSN
2949-866X
Country
China
Languages
english
Access
Open access
Declared publication charge
1,200 USD
Articles in DOAJ
193
Declared review time
20 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2025-09-06
Indexing
DOAJ
APC
1,200 USD
Declared review time (DOAJ)
20 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

193

Most recent article

3 months ago

Average review time (journal-declared via DOAJ)

20weeks

Works in OpenAlex

220

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

24

i10-index

63

From OpenAlex open data (CC0).

Editorial & policy10
Last DOAJ review date
2025-09-06
Added to DOAJ
2025-09-06
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
90%
ORCID iDs in current deposits
62%
Deposits licence metadata at Crossref
✓
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Therapeutics. Pharmacology

LCC codes

RM1-950

Subject areas

  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Educational Robotics and Engineering
  • Diverse Scientific and Economic Studies
  • Human auditory perception and evaluation
  • Human auditory perception and evaluation
  • Diverse Scientific and Economic Studies
  • Educational Robotics and Engineering
Show all subjects (50)
  • Advanced Drug Delivery Systems
  • Advanced Drug Delivery Systems
  • Advancements in Transdermal Drug Delivery
  • Advancements in Transdermal Drug Delivery
  • Artificial Intelligence in Healthcare and Education
  • Artificial Intelligence in Healthcare and Education
  • Drug Solubulity and Delivery Systems
  • Drug Solubulity and Delivery Systems
  • Synthesis and biological activity
  • Synthesis and biological activity
  • COVID-19 diagnosis using AI
  • COVID-19 diagnosis using AI
  • Artificial Intelligence in Healthcare
  • Artificial Intelligence in Healthcare
  • Nanoparticle-Based Drug Delivery
  • Nanoparticle-Based Drug Delivery
  • Natural Antidiabetic Agents Studies
  • Natural Antidiabetic Agents Studies
  • Antibiotics Pharmacokinetics and Efficacy
  • Biomedical and Engineering Education
  • Biomedical and Engineering Education
  • Machine Learning in Healthcare
  • Antibiotics Pharmacokinetics and Efficacy
  • Phytochemicals and Antioxidant Activities
  • Genetics, Bioinformatics, and Biomedical Research
  • Machine Learning in Healthcare
  • 3D Printing in Biomedical Research
  • Phytochemicals and Antioxidant Activities
  • Pharmacological Effects of Natural Compounds
  • Essential Oils and Antimicrobial Activity
  • Genetics, Bioinformatics, and Biomedical Research
  • 3D Printing in Biomedical Research
  • Essential Oils and Antimicrobial Activity
  • Pharmacological Effects of Natural Compounds
  • Prostate Cancer Treatment and Research
  • Innovative Microfluidic and Catalytic Techniques Innovation
  • Antibiotic Resistance in Bacteria
  • Prostate Cancer Treatment and Research
  • Antibiotic Resistance in Bacteria
  • Nanoparticles: synthesis and applications
  • Pharmaceutical Practices and Patient Outcomes
  • Nanoparticles: synthesis and applications

Keywords (DOAJ)

  • pharmacy
  • pharmacology
  • computer science
  • artificial intelligence
  • drug design
  • hospital pharmacy

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: